Alvotech
ALVO · Nasdaq Iceland / Nasdaq US · Health Care – Biotechnology · US listing: ALVO
About the company
Alvotech is a biopharmaceutical company specialising in the development and manufacture of biosimilar medicines for patients worldwide. Founded by Icelandic-Lebanese billionaire Robert Wessman, the company is headquartered in Reykjavík and has a manufacturing facility in Iceland. It is dual-listed on Nasdaq in the United States and on Nasdaq Iceland.
| Exchange | Nasdaq Iceland / Nasdaq US |
| Ticker | ALVO |
| Sector | Health Care – Biotechnology |
| US listing | ALVO |
| Indicative market cap USD | $1.70B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
Trades in the US as ALVO, available through most US brokerage accounts.
On its home market (Nasdaq Iceland / Nasdaq US), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Iceland — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Iceland
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.